Abbott Laboratories: Organic Growth Will Be Key To Q1 Earnings (NYSE:ABT)


Share post:


In my previous Abbott Laboratories (NYSE:ABT) article, I discussed the company’s Q3 2023 earnings, revealing a significant resurgence in their primary business segments. The decline in COVID-19 testing-related revenue did not stop Abbott from pulling in $10.1B for the quarterreportedApril 17th


Please enter your comment!
Please enter your name here

Related articles

10 States Where Workers Earn the Least Money

Ever wonder where people take home the smallest paychecks? The federal Bureau of Labor Statistics keeps data on...

These Goliath SEO Sites are Seeing MASSIVE Growth

Welcome back to another episode of the Niche Pursuits News podcast, where Spencer and Jared break down...

Departing Boeing CEO Dave Calhoun cut his bonus in 2024 after the door plug flew off an Alaska Airlines flight

The Boeing board is pledging to get the airline manufacturer back on track, and new independent Chairman...

Going once, going twice…Open Enrollment ends soon!

Published on January 11, 2024The clock is ticking for you to get health coverage for 2024. Open...